title: Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Fasano
authors.forename: Magda
authors.initials: M
authors.lastname: D'Agostino
authors.forename: Giacomo
authors.initials: G
authors.lastname: Caldarola
authors.forename: Claudio
authors.initials: C
authors.lastname: Feliciani
authors.forename: Clara
authors.initials: C
authors.lastname: De Simone
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy* / Q000473:pathology; D000529:Complementary Therapies; D018432:Drug Resistance, Multiple; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D012074:Remission Induction; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab